Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
170 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00261846 | Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias | completed | Phase 2 | 571 | PfizerINDUSTRY | 27 | Jul 27, 2017 | clinicaltrials |
| NCT02016534 | Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors | terminated | Phase 2 | 60 | AmgenINDUSTRY | 18 | Jul 2, 2017 | clinicaltrials |
| NCT01013740 |
| Lapatinib in Combination With Vinorelbine(VITAL) |
| completed |
| Phase 2 |
| 112 |
| Novartis PharmaceuticalsINDUSTRY |
| 10 |
| May 31, 2017 |
| clinicaltrials |
| NCT01493843 | Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer | completed | Phase 2 | 501 | Genentech, Inc.INDUSTRY | 16 | Apr 25, 2017 | clinicaltrials |
| NCT00089999 | Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer | completed | Phase 2 | 138 | GlaxoSmithKlineINDUSTRY | 11 | Feb 28, 2017 | clinicaltrials |
| NCT01437566 | Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor Therapy | completed | Phase 2 | 318 | Genentech, Inc.INDUSTRY | 23 | Nov 2, 2016 | clinicaltrials |
| NCT00124566 | Study of Irofulven in Patients With Hormone-refractory Prostate Cancer | completed | Phase 2 | 135 | Eisai Inc.INDUSTRY | 9 | Jan 18, 2016 | clinicaltrials |
| NCT01263886 | Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer(DISRUPT) | completed | Phase 2 | 176 | SanofiINDUSTRY | 13 | Dec 21, 2015 | clinicaltrials |
| NCT00560235 | Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors | completed | Phase 1 / Phase 2 | 138 | PfizerINDUSTRY | 11 | Oct 28, 2015 | clinicaltrials |
| NCT01500720 | Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer | completed | Phase 2 | 179 | SanofiINDUSTRY | 16 | Apr 13, 2015 | clinicaltrials |
| NCT01010295 | A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae(IELSG27) | completed | Phase 2 | 54 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 4 | Nov 25, 2013 | clinicaltrials |
| NCT00530764 | A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.(SPRAY) | completed | Phase 2 | 360 | GW Pharmaceuticals LtdINDUSTRY | 16 | Jun 20, 2013 | clinicaltrials |
| NCT00558103 | Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer | completed | Phase 2 | 163 | GlaxoSmithKlineINDUSTRY | 28 | Feb 4, 2013 | clinicaltrials |
| NCT00370383 | A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC) | completed | Phase 2 | 100 | AgennixINDUSTRY | 3 | Aug 7, 2012 | clinicaltrials |
| NCT00630110 | Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 172 | Nereus Pharmaceuticals, Inc.INDUSTRY | 6 | Aug 16, 2011 | clinicaltrials |
| NCT00145639 | Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma | completed | Phase 2 | 80 | St. Jude Children's Research HospitalOTHER | 2 | Jun 10, 2011 | clinicaltrials |
| NCT00550004 | Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine(RP101) | terminated | Phase 2 | 153 | SciClone PharmaceuticalsINDUSTRY | 13 | Jun 8, 2011 | clinicaltrials |
| NCT00169572 | Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy | completed | Phase 2 | 492 | GlaxoSmithKlineINDUSTRY | 19 | May 10, 2010 | clinicaltrials |
| NCT00174863 | Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer(ODYSSEY) | completed | Phase 2 | 232 | SanofiINDUSTRY | 13 | Dec 23, 2008 | clinicaltrials |
| NCT00191620 | Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer. | completed | Phase 2 | 64 | Eli Lilly and CompanyINDUSTRY | 4 | Jan 26, 2007 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials